Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - USD ($)	1 Months Ended			3 Months Ended	9 Months Ended
	Aug. 31, 2021	May 31, 2021	Feb. 28, 2021	Nov. 30, 2021	Nov. 30, 2022	Nov. 30, 2021	Feb. 28, 2018
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) [Line Items]
Accumulated deficit					$ 136,004
Net decrease in fair value	$ 127,420	$ 56,640
Increase in fair value					734,106
Other income				$ 734,106
Aggregate other income						$ 550,046
Decrease in fair value						594,666
Expiring warrants						44,620
Gain on its extinguishment					133,500
Additional paid-in capital					136,004
Stock compensation expense				163,218		489,654
Recognition expense				68,862		153,388
Compensation expense				91,356	276,606
Accrued interest	$ 8,064
Cumulative accrued interest				$ 8,064		$ 8,064
Adjustment [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) [Line Items]
Warrant derivative liability			$ 1,366,375
Accumulated deficit			1,366,375				$ 256,044
Interest expense debt					13,460
Additional paid-in capital					258,636
Compensation expense					(153,388)
Stock options [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) [Line Items]
Accumulated deficit					$ 258,636
Stock compensation expense			$ 258,636